A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis

Trial Profile

A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Retinal oedema; Uveitis
  • Focus Therapeutic Use
  • Acronyms DOGWOOD
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 09 Nov 2016 According to a Clearside Biomedical media release, data from the study has been presented at the American Society of Retina Specialists annual meeting in August 2016.
    • 10 Oct 2016 According to a Clearside Biomedical media release, results from the study will be presented at the Retina Sub-Specialty Day Meeting at the 2016 American Academy of Ophthalmology (AAO) Meeting.
    • 03 Aug 2016 According to a Clearside Biomedical media release, combined results from this and a phase I study (Profile 700243256) will be presented at the 2016 Annual Meeting of the American Society of Retina Specialists (ASRS).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top